5-Hydroxylansoprazole (AG1908) is an active metabolite of Lansoprazole in plasma. Lansoprazole is a gastric proton-pump inhibitor and is effective in the treatment of various peptic diseases[1][2]. Lansoprazole is metabolized by CYP2C19 forming 5-Hydroxylansoprazole.

131926-98-2

C16H14F3N3O3S

385.36

AG1908

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years